• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗逆转录病毒药物2'-脱氧-2'-β-氟-4'-叠氮胞苷(FNC)对P-糖蛋白、多药耐药相关蛋白2和乳腺癌耐药蛋白表达及功能的影响。

Effects of the antiretroviral drug 2'-deoxy-2'-β-fluoro-4'-azidocytidine (FNC) on P-gp, MRP2 and BCRP expressions and functions.

作者信息

Liu Yixian, Wang Yafeng, Peng Youmei, Liu Bingjie, Ma Fang, Jiang Jinhua, Wang Qingduan, Chang Junbiao

出版信息

Pharmazie. 2018 Sep 1;73(9):503-507. doi: 10.1691/ph.2018.8555.

DOI:10.1691/ph.2018.8555
PMID:30223932
Abstract

The purpose of the present study was to dig into recent studies designed to characterize the impacts of 2'-deoxy-2'-β-fluoro-4'-azidocytidine (FNC) on P-glycoprotein (P-gp), multidrug resistance-associated protein 2 (MRP2) and breast cancer resistance protein (BCRP). Specifically, the modulation effects of FNC on P-gp, MRP2 and BCRP protein expressions were assessed by western blot methods. 5 (and 6)-Carboxy-2',7'-dichloroflourescein (CDF) and BODIPY-prazosin were used to provide indications of alterations of MRP2 and BCRP activities. The effects of P-gp, MRP2 and BCRP on FNC were evaluated in the in situ single-pass intestinal perfusion model. The results showed that FNC at higher concentrations and with longer incubation times can upregulate the protein expression of P-gp, MRP2 and BCRP in Caco-2 cells. The upregulated proteins were also functionally active, as revealed by a lower degree of CDF and BODIPY-prazosin uptake by the cell monolayers. The intestinal absorptive coefficient (Peff) was observed to significantly increase with the inhibitors of P-gp, MRP2 and BCRP. These results suggested that FNC could modulate the expressions and functions of P-gp, MRP2 and BCRP, while P-gp, MRP2 and BCRP were involved in the efflux transport of FNC. The inductive effects of FNC on P-gp, MRP2 and BCRP suggested the possibility of FNC to contribute to the inter- and intra-individual variability of itself, as well as to alter the absorption of other drugs that may be administered concomitantly.

摘要

本研究的目的是深入探究最近旨在表征2'-脱氧-2'-β-氟-4'-叠氮胞苷(FNC)对P-糖蛋白(P-gp)、多药耐药相关蛋白2(MRP2)和乳腺癌耐药蛋白(BCRP)影响的研究。具体而言,通过蛋白质印迹法评估FNC对P-gp、MRP2和BCRP蛋白表达的调节作用。使用5(和6)-羧基-2',7'-二氯荧光素(CDF)和BODIPY-哌唑嗪来指示MRP2和BCRP活性的变化。在原位单通道肠道灌注模型中评估P-gp、MRP2和BCRP对FNC的影响。结果表明,较高浓度且孵育时间较长的FNC可上调Caco-2细胞中P-gp、MRP2和BCRP的蛋白表达。上调的蛋白也具有功能活性,这通过细胞单层对CDF和BODIPY-哌唑嗪的摄取程度较低得以揭示。观察到肠道吸收系数(Peff)随着P-gp、MRP2和BCRP的抑制剂而显著增加。这些结果表明,FNC可调节P-gp、MRP2和BCRP的表达和功能,而P-gp、MRP2和BCRP参与FNC的外排转运。FNC对P-gp、MRP2和BCRP的诱导作用表明,FNC有可能导致其自身的个体间和个体内变异性,并改变可能同时给药的其他药物的吸收。

相似文献

1
Effects of the antiretroviral drug 2'-deoxy-2'-β-fluoro-4'-azidocytidine (FNC) on P-gp, MRP2 and BCRP expressions and functions.抗逆转录病毒药物2'-脱氧-2'-β-氟-4'-叠氮胞苷(FNC)对P-糖蛋白、多药耐药相关蛋白2和乳腺癌耐药蛋白表达及功能的影响。
Pharmazie. 2018 Sep 1;73(9):503-507. doi: 10.1691/ph.2018.8555.
2
Intestinal absorption mechanisms of 2'-deoxy-2'-β-fluoro-4'-azidocytidine, a cytidine analog for AIDS treatment, and its interaction with P-glycoprotein, multidrug resistance-associated protein 2 and breast cancer resistance protein.2'-脱氧-2'-β-氟-4'-叠氮胞苷(一种用于治疗艾滋病的胞苷类似物)的肠道吸收机制及其与P-糖蛋白、多药耐药相关蛋白2和乳腺癌耐药蛋白的相互作用
Eur J Pharm Sci. 2017 Jul 15;105:150-158. doi: 10.1016/j.ejps.2017.05.009. Epub 2017 May 6.
3
Knockout Transporter Cell Lines to Assess Substrate Potential Towards Efflux Transporters.建立敲除转运体的细胞系以评估底物对外排转运体的潜在作用。
AAPS J. 2024 Jul 10;26(4):79. doi: 10.1208/s12248-024-00950-6.
4
Prandial state and biological sex modulate clinically relevant efflux transporters to different extents in Wistar and Sprague Dawley rats.在Wistar大鼠和Sprague Dawley大鼠中,进食状态和生物性别对临床相关外排转运体的调节程度不同。
Biomed Pharmacother. 2023 Apr;160:114329. doi: 10.1016/j.biopha.2023.114329. Epub 2023 Jan 31.
5
Small intestinal efflux mediated by MRP2 and BCRP shifts sulfasalazine intestinal permeability from high to low, enabling its colonic targeting.由多药耐药相关蛋白2(MRP2)和乳腺癌耐药蛋白(BCRP)介导的小肠外排作用将柳氮磺胺吡啶的肠道通透性从高转变为低,从而实现其结肠靶向性。
Am J Physiol Gastrointest Liver Physiol. 2009 Aug;297(2):G371-7. doi: 10.1152/ajpgi.00102.2009. Epub 2009 Jun 18.
6
Differential selectivity of efflux transporter inhibitors in Caco-2 and MDCK-MDR1 monolayers: a strategy to assess the interaction of a new chemical entity with P-gp, BCRP, and MRP2.Caco-2 和 MDCK-MDR1 单层细胞中外排转运蛋白抑制剂的差异选择性:评估新化学实体与 P-糖蛋白、BCRP 和 MRP2 相互作用的策略。
J Pharm Sci. 2012 May;101(5):1888-97. doi: 10.1002/jps.23069. Epub 2012 Feb 22.
7
Glyceollin Effects on MRP2 and BCRP in Caco-2 Cells, and Implications for Metabolic and Transport Interactions.大豆抗毒素对Caco-2细胞中多药耐药相关蛋白2(MRP2)和乳腺癌耐药蛋白(BCRP)的影响及其对代谢和转运相互作用的意义
J Pharm Sci. 2016 Feb;105(2):972-981. doi: 10.1002/jps.24605. Epub 2016 Jan 11.
8
Comparative Hepatic and Intestinal Efflux Transport of Statins.他汀类药物的肝脏和肠道外排转运比较
Drug Metab Dispos. 2021 Sep;49(9):750-759. doi: 10.1124/dmd.121.000430. Epub 2021 Jun 23.
9
Liver X receptor regulates expression of MRP2 but not that of MDR1 and BCRP in the liver.肝脏X受体调节肝脏中多药耐药相关蛋白2(MRP2)的表达,但不调节多药耐药蛋白1(MDR1)和乳腺癌耐药蛋白(BCRP)的表达。
Biochim Biophys Acta. 2009 Nov;1788(11):2396-403. doi: 10.1016/j.bbamem.2009.08.014. Epub 2009 Sep 1.
10
Zinc finger nuclease-mediated gene knockout results in loss of transport activity for P-glycoprotein, BCRP, and MRP2 in Caco-2 cells.锌指核酸酶介导的基因敲除导致Caco-2细胞中P-糖蛋白、乳腺癌耐药蛋白(BCRP)和多药耐药相关蛋白2(MRP2)的转运活性丧失。
Drug Metab Dispos. 2015 Feb;43(2):199-207. doi: 10.1124/dmd.114.057216. Epub 2014 Nov 11.

引用本文的文献

1
Advances in the effectiveness and safety of azvudine treatment: a comprehensive review.阿兹夫定治疗的有效性和安全性进展:一项全面综述。
Front Pharmacol. 2025 Apr 25;16:1524072. doi: 10.3389/fphar.2025.1524072. eCollection 2025.
2
Efficacy and safety of azvudine in patients with COVID-19: A systematic review and meta-analysis.阿兹夫定治疗新型冠状病毒肺炎患者的疗效与安全性:一项系统评价与荟萃分析
Heliyon. 2023 Sep 14;9(9):e20153. doi: 10.1016/j.heliyon.2023.e20153. eCollection 2023 Sep.
3
2023 Chinese expert consensus on the impact of COVID-19 on the management of cardiovascular diseases.
《2023年新型冠状病毒肺炎对心血管疾病管理影响的中国专家共识》
Cardiol Plus. 2023 Apr-Jun;8(2):82-102. doi: 10.1097/CP9.0000000000000043. Epub 2023 Jul 20.
4
Safety Assessment of a Nucleoside Analogue FNC (2'-deoxy-2'- β-fluoro-4'-azidocytidine ) in Balb/c Mice: Acute Toxicity Study.核苷类似物 FNC(2'-脱氧-2'-β-氟-4'-叠氮胞苷)在 Balb/c 小鼠中的安全性评估:急性毒性研究。
Asian Pac J Cancer Prev. 2023 Jun 1;24(6):2157-2170. doi: 10.31557/APJCP.2023.24.6.2157.
5
Multidrug efflux transporter ABCG2: expression and regulation.多药外排转运蛋白 ABCG2:表达与调控。
Cell Mol Life Sci. 2021 Nov;78(21-22):6887-6939. doi: 10.1007/s00018-021-03901-y. Epub 2021 Sep 29.